5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The North American Fluoroscopy Devices Market is segmented by Device Type, Application (Orthopedic, Cardiovascular, Pain Management, and Trauma, Neurology, Gastrointestinal, Urology, General Surgery, and Other Applications), and Geography.
The North America Fluoroscopy Devices Market is expected to register a CAGR of 4.5% during the forecast period. The major factors driving the growth of the market in North America are due to the presence of established healthcare infrastructure, technological advancements, rising demand for minimally-invasive surgeries, growing geriatric population and prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
According to the World Ageing 2019 report, estimated that in 2019 there were about 53.340 million (16.2%) population aged 65 years or over in the United States. This number is projected to reach 70.842 million (20.3%) in 2030. As the number of the elderly population is expected to increase in the near future and this population is more prone to chronic conditions such as cardiovascular, neurological disorders, and other diseases which will show a positive impact on the market.
Furthermore, according to the American Heart Association Research, approximately 2,300 Americans die due to cardiovascular diseases each day, an average of one death for every 38 seconds.
Thus, owing to above factors the market is expected to show signifcant growth over the forecast period. However, the side effects associated with radiation is expected to hinder the market growth over the forecast period.
As per the scope of the report, fluoroscopy refers to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, the fluoroscopy produces live moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. A typical fluoroscope has four components, which include an X-ray source, an X-ray image intensifier, an imaging system, and a work station. The North American Fluoroscopy Devises Market is segmented by device type, application, and geography.
|By Device Type|
|Pain Management and Trauma|
Report scope can be customized per your requirements. Click here.
The rising burden of cardiovascular diseases in North America is a major factor driving the growth of the market. For instance, according to the Heart Disease and Stroke Statistics 2019 report, estimates that in 2019, coronary events were expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events in the United States.
As per the Heart and Stroke Foundation 2019 report, each year more than 62,000 people get attack with stroke in Canada, and that number is expected to rise. More than 405,000 people in the country live with the effects of stroke. Furthermore, the number of people who die in the hospital within 90 days is 7.6 times higher for people with heart valve disease and heart failure in comparison to heart valve disease alone.
Furthermore, increasing cardiovascular diseases, such as high blood pressure, arrhythmias, and stroke are increasing the demand for fluoroscopy devices, along with growing demand for minimally invasive surgeries and technological advancements are also expected to drive the market in the near future.
To understand key trends, Download Sample Report
The North American Fluoroscopy Devises Market is consolidated competitive. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the players who are currently dominating the market are GE Healthcare (GE Company), Carestream Health, Canon Medical Systems Corporation, Siemens Healthineers, Koninklijke Philips NV, Hologic Inc, Orthoscan Inc, Shimadzu Medical and Varian Medical Systems Inc.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally-invasive Surgeries
4.2.2 Growing Geriatric Population and Prevalence of Chronic Diseases
4.2.3 Increasing Use of Fluoroscopy in Pain Management
4.3 Market Restraints
4.3.1 Side Effects and Radiation Exposure
4.3.2 Rising Adoption of Refurbished Systems
4.3.3 Stringent Regulations for Imaging Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Fixed Fluoroscopes
5.1.2 Mobile Fluoroscopes
220.127.116.11 Full-size Fluoroscopes
18.104.22.168 Mini Fluoroscopes
5.2 By Application
5.2.3 Pain Management and Trauma
5.2.7 General Surgery
5.2.8 Other Applications
5.3.1 North America
22.214.171.124 United States
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare (GE Company)
6.1.2 Carestream Health
6.1.3 Canon Medical Systems Corporation
6.1.4 Siemens Healthineers
6.1.5 Koninklijke Philips NV
6.1.6 Hologic Inc
6.1.7 Orthoscan Inc
6.1.8 Shimadzu Medical
6.1.9 Varian Medical Systems Inc
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments